UW spinout TwinStrand has completed a $50m series B round led by Section 32, while Alexandria Venture Investments invested a third time.
TwinStrand Biosciences, a US-based genetic sequencing technology spinout of University of Washington, closed a $50m series B round yesterday led by Section 32.
Alexandria Venture Investments, a vehicle for life sciences real estate investment trust Alexandria Real Estate Equities, also took part, as did Soleus Capital, Janus Henderson Investors, Madrona Venture Group, Ridgeback Capital and unnamed existing backers.
Founded in 2015, TwinStrand has developed a biochemistry and software-based platform that identifies ultra-low frequency DNA mutations with a resolution…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
